Tremor
Acadia Pharmaceuticals Secures Exclusive Licensing Deal for Saniona’s Tremor Treatment Asset Worth Up to $582 Million
Acadia Pharmaceuticals, Saniona, tremor treatment, licensing deal, biobucks, neurological disorder
Actionable Insights Powered by AI
Acadia Pharmaceuticals, Saniona, tremor treatment, licensing deal, biobucks, neurological disorder